Featured Research

from universities, journals, and other organizations

HIV-infected Have Thicker Carotid Artery Walls--Predictor Of Heart Attack & Stroke

Date:
March 19, 2004
Source:
University Of California - San Francisco
Summary:
Carotid artery intima-media thickness (IMT) -- a potent predictor of heart attack and stroke -- is significantly higher in HIV-infected patients compared to uninfected controls, according to study results from UCSF researchers.

With the advent of antiretroviral medication, HIV patients are living longer and facing yet another health challenge.

Related Articles


Carotid artery intima-media thickness (IMT) -- a potent predictor of heart attack and stroke -- is significantly higher in HIV-infected patients compared to uninfected controls, according to study results from UCSF researchers. In addition after one year of follow-up, carotid artery IMT progressed significantly faster in HIV-infected individuals.

"Our findings suggest that it would be reasonable to consider HIV infection a cardiac risk factor. Other risk factors, such as high cholesterol and high blood pressure need to be aggressively treated in HIV patients -- even it if means changes in their HIV medications." said the study's lead author, Priscilla Hsue, MD, assistant professor of medicine at UCSF.

The study, published in the April 6th issue of Circulation, found that HIV infection was an independent predictor of carotid artery IMT along with age, LDL-cholesterol levels, and cigarette smoking. Duration of protease inhibitor therapy was not associated with thicker carotid IMT.

Carotid IMT progression over one year was greater among the 121 HIV patients with follow-up measurements. IMT progression was associated with older age, Latino race, and a history of a low CD4 cell count.

In order to address cardiovascular issues in HIV patients, Hsue is opening one of the first cardiac sub-specialty clinics for HIV patients at the UCSF Positive Health Program based at San Francisco General Hospital Medical Center (SFGHMC).

"The greater rate of progression in arterial thickening among HIV patients is a cause for concern because it indicates that these patients could experience more vascular events in the future. Our primary motivation for starting a cardiac specialty clinic was to address cardiac issues and risk factors in HIV patients and to try and prevent cardiac complications before they occur," said Hsue.

Study co-authors are Joan C. Lo, MD, UCSF assistant adjunct professor of medicine at the General Clinical Research Center; Arlana Franklin, RDMS, UCSF senior technologist; Ann F. Bolger, MD, UCSF associate professor of clinical medicine; Steven G. Deeks, MD, UCSF associate professor of clinical medicine at the Positive Health Program; and David D. Waters, MD, UCSF professor of medicine, all at SFGHMC; and Jeffrey N. Martin, MD, MPH, UCSF assistant professor in the Department of Epidemiology and Biostatistics.

The study was conducted at the General Clinical Research Center at SFGHMC. It was funded by grants from the Doris Duke Charitable Foundation, the National Institutes of Health, the California AIDS Research Center, the UCSF Academic Senate, the UCSF/Gladstone Institute for Virology and Immunology Center for AIDS Research, and Astra Zeneca.


Story Source:

The above story is based on materials provided by University Of California - San Francisco. Note: Materials may be edited for content and length.


Cite This Page:

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins